Dr Claudia Götz Staehelin > Bär & Karrer Ltd. > Zurich, Switzerland > Lawyer Profile

Bär & Karrer Ltd.
BRANDSCHENKESTRASSE 90
8027 ZÜRICH
Switzerland

Position

Claudia Götz Staehelin’s practice focuses on complex investigation and litigation matters at the intersection of civil, criminal and regulatory proceedings. Claudia leads large-scale internal investigations, supports her clients in crisis management and advises them on all aspects of their compliance framework. She represents and advises her clients in domestic and cross-border litigations, in international judicial and administrative assistance matters and in internal and regulatory investigations led by Swiss and foreign authorities. One of her industry focuses is the Healthcare & Life Sciences industry, where she advises clients on pharma regulatory and all compliance matters.

Based on her experience as former Head of Litigation at Novartis, Claudia regularly supports companies with multi-jurisdictional projects requiring innovative thinking. She has extensive international experience in litigation and investigation risk assessment, and in assisting clients with strategic decision-making. Her many years in-house and with corporate investigations have given her a deep understanding of the challenges and opportunities of ESG issues for companies.

Career

  • Partner at a Swiss commercial law firm (2018-2023)
  • Head Litigation of Novartis (2011-2018)
  • Partner at a Zurich law firm (2007-2011)
  • Associate at a Swiss commercial law firm (2002-2007)
  • Admitted to the Basel-Stadt bar (2001)

Languages

German, English

Memberships

  • Ethics and Compliance Switzerland (ECS) (Board Member)
  • Women in White Collar Defense Association (Swiss Chapter)
  • Association of Certified Fraud Examiners (ACFE)
  • The Sedona Conference
  • International Association of Privacy Professionals (IAPP)
  • Swiss Arbitration Association (ASA)

Education

  • LL.M., New York University, School of Law, Vanderbilt Scholar, specialization in US litigation (2005)
  • University of Basel: Dr. iur. (2000)
  • University of Basel: lic. iur. (1998)

Lawyer Rankings

Switzerland > Regulatory, compliance and investigations

(Leading Individuals)

Claudia Götz StaehelinBär & Karrer Ltd.

Operating in Bär & Karrer Ltd.‘s Geneva office, Saverio Lembo and Andrew Garbarski lead the white-collar crime group, which advises across the full spectrum of alleged business crimes. Zurich-based Eric Stupp, Joel Fischer and Andreas Länzlinger head the crisis management and internal investigations team, which demonstrates significant prowess in managing cross-border mandates. Basel-based Claudia Götz Staehelin and Oliver M. Brupbacher round out the team’s leadership, contributing their vast expertise in the life sciences and healthcare sector to the practice, having joined from Kellerhals Carrard in April 2023. Other key undertakings for the team, regarded as a ‘leader in Switzerland’, include corporate governance, compliance processes and regulatory issues, alongside a host of others.

Switzerland > Dispute resolution: litigation

Regarded as a team of ‘highly responsive strategic thinkers’, Bär & Karrer Ltd. represents clients across a broad scope of litigation, ranging from insurance and employment law litigation, to disputes involving trusts and estates and bankruptcy-related proceedings. Alongside this, the practice demonstrates considerable proficiency across financial services, healthcare, energy and sports sectors, among others. The practice is jointly led by Matthew Reiter, Aurélie Conrad Hari and Cesare Jermini. Reiter’s particular expertise lies in the remit of complex domestic and international commercial disputes, while Conrad Hari bolsters the practice with her capabilities across financial, banking and commercial disputes. Jermini’s wide-ranging experience encompasses commercial law, private international law and real estate, to name a few. Nadja Jaisli Kull is especially active in the banking and finance, pharma and transport fields, with Andreas Länzlinger possessing a wealth of experience in handling large scale internal investigations at global enterprises. Andrew Garbarski and Saverio Lembo are also key members of the practice. Claudia Götz Staehelin and Oliver M. Brupbacher both joined from Kellerhals Carrard in April 2023, adding significant life sciences capabilities to the team.

Switzerland > Healthcare and life sciences

(Leading individuals)

Claudia Götz StaehelinBär & Karrer Ltd.

The market-leading team at Bär & Karrer Ltd. advises its lucrative client base of on the full gamut of matters, including the marketing and advertising of drugs and pricing proceedings. Jointly heading the practice in Zurich, Markus Schott primarily focuses on administrative proceedings, including government supervision and public procurement mandates; Markus Wang  leads on the intellectual property (IP) side, acting for pharma and biotech clients in Swissmedic proceedings; and Philippe Seiler maintains a private equity and M&A focused practice, handling a variety of transactions and regulatory matters involving medical device and drug distribution. Basel based practice co-head Claudia Götz Staehelin is an expert in investigations, disputes, and regulatory issues, representing numerous global pharma giants, while co-head Oliver Brupbacher is noted for his ‘exceptional‘ sector knowledge, and his expertise in crisis management issues and information governance. Jannick Koller left the practice in December 2022.

Comparative Guides

Switzerland: Product Liability April 2024 This country-specific Q&A provides an overview of Product Liability laws and regulations applicable in Switzerland.
Switzerland: Life Sciences March 2024 This country-specific Q&A provides an overview of Life Sciences laws and regulations applicable in Switzerland.